Roche Survey Highlights Asia Pacific’s Silent Struggle with Eye Care
Preventable blindness is rising across Asia Pacific, and a new survey uncovers the reasons why. A newly released APAC Vision…
FDA Rejects Regeneron’s sBLA to Extend EYLEA HD Dosing Interval
Regeneron’s proposal to lengthen EYLEA HD dosing intervals to 24 weeks hits a CRL roadblock. The wait for extended treatment…
latest posts
